Guidelines Development Group for Consolidated guidelines ...
Transcript of Guidelines Development Group for Consolidated guidelines ...
Guidelines Development Group for Consolidated guidelines on the management of latent tuberculosis infection.
Disclaimer
In order to enhance its management of conflicts of interest as well as strengthen public trust and
transparency in connection with WHO meetings and activities involving the provision of
technical/normative advice, the names and brief biographies of individuals (“Published Information”)
being considered for participation in a WHO-convened Guideline Development Group are disclosed
for public notice and comment.
The Published Information is provided by the experts themselves and is the sole responsibility of the
individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the
Published Information provided. Furthermore, in no event will WHO be responsible or liable for
damages in relation to the use of, and reliance upon, the Published Information.
The comments received by WHO through the public notice and comment process are treated
confidentially and their receipt will be acknowledged through a generic email notification to the
sender. Comments brought to the attention of WHO through this process are an integral component of
WHO’s conflict of interest assessment process and are carefully reviewed. WHO reserves the right to
discuss information received through this process with the relevant expert and disclose to this expert
the name and affiliation of the provider of such information. Upon review and assessment of the
information received through this process, WHO, in its sole discretion, may take appropriate
management action in accordance with its policies.
Guideline Development Groups provide technical and/or normative advice and recommendations to
WHO. Participation in a Guideline Development Group convened by WHO does not necessarily
mean that the views expressed by the expert concerned are shared by WHO and/or represent the
decisions or stated policy of WHO.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any
appropriate mitigation measures taken by WHO relating to the management of conflicts of interests,
will be reported publically in accordance with WHO policies.
Biographies of members of the Guideline Development Group
Name: Mohammed Redha Al Lawati
Institutional affiliation(s): Consultant Physician
Former Head of National HIV/AIDS, TB & Leprosy Control Programs
Academic degrees: MBBS, MSc
City and country of primary residence: Muscat, Oman
Biography
Dr Mohammed Al Lawati was trained in Respiratory Medicine in Brompton Hospital London
and in Respiratory & HIV Medicine in St. Vincent’s Hospital and St. George’s Hospital
Sydney. After returning from his training, he played key role in developing Respiratory, HIV
and Tuberculosis Services in Oman. He currently serves as Consultant Physician in KIMS
Hospital Oman and until recently, as Head of National AIDS, TB and Leprosy Control
Programs in MOH, Oman. Dr Mohammed has participated in teaching of undergraduate
students and in 1999 was awarded as one of the best clinical tutors by Sultan Qaboos
University. He also actively participates in the training of doctors in management of Asthma,
HIV and Tuberculosis and has played pivotal role in forming National Guidelines for the
management of Tuberculosis, Asthma and HIV/AIDS. Dr Mohammed has published papers
in the national and International Journals on Tuberculosis and HIV/AIDS. He is the founding
member of Oman Respiratory Society and previously has served as its Vice President. He
served as member of Global Validation Advisory Committee of WHO, for Elimination of
Mother to Child Transmission of HIV infection.
Name: Rolando A. Cedillos
Institutional affiliation(s): Chief of Infectious Diseases at Hospital Nacional Rosales and
Professor of Medicine at the University of El Salvador.
Academic degrees: M.D. MSc. DTM&H
City and country of primary residence: San Salvador,El Salvador
Biography
Born August 16, 1959 in San Salvador, El Salvador. Graduated as a Doctor in Medicine at
the University of El Salvador. Completed residency in Internal Medicine at Hospital Nacional
Rosales in El Salvador in 1996.
MSc in Infection & Health in the Tropics (Tropical Medicine & International Health) at the
London School of Hygiene & Tropical Medicine and Diploma in Tropical Medicine &
Hygiene from the Royal College of Physicians, United Kingdom in 1997.
Since 1998 Chief of Infectious Diseases at Hospital Nacional Rosales and Professor of
Medicine at the University of El Salvador.
Collaborator of the World Health Organization (WHO) and the Pan American Health
Organization (PAHO) in the clinical management of Tuberculosis and HIV.
Author and presenter of works on the natural history of HIV, access to retroviral treatment in
Central America and of the book “La Epidemia Invisible” Historias del SIDA en El Salvador
currently on translation as “The Invisible Epidemic” a Central American AIDS memoir.
Name: Anna Marie Celina Garfin
Institutional affiliation(s): Infectious Diseases for Prevention and Control Division, Disease
Prevention and Control Bureau, Department of Health
Academic degrees: MD, MM
City and country of primary residence: Quezon City, Philippines
Biography
Since 1999 as a staff of the National Tuberculosis Control Program of the Department of
Health has been involved in the development of policies and guidelines, training modules,
manual of operations and standards in the implementation of the National TB Control
Program in the country. I was also involved in the formulation of the clinical practice
guidelines for the diagnosis, treatment, prevention and control of TB in adults and children
spearheaded by the Philippine Coalition against Tuberculosis and the various Professional
Medical Societies.
List of relevant outputs are the following: Manual of Procedures for the National
Tuberculosis Control Program, 4th
and 5th
edition (2005 and 2014), The Health Promotion
Handbook (2008) and various polices release as administrative orders for TB control Program
implementation.
Relevant trainings attended are the following: Training to Develop Consultancy Skills on
Programmatic Management of Drug-Resistant Tuberculosis in the Western Pacific Region by
WHO last December 3 to 7, 2012 in Manila, Philippines; Advance Course in TB Control
Management by Japan International Cooperation Agency last January 11, 2005 – February 5,
2005 at the Research Institute of TB, Japan Anti-TB Association; and the Field Epidemiology
Training Program of the Department of Health.
Name: Padmapriyadarsini Chandrasekaran
Institutional affiliation(s): Deputy Director (Medical)
National Institute for Research in Tuberculosis
[Indian Council for Medical Research]
Mayor Sathyamoorthy Road, Chetput,
Chennai 600 031
Academic degrees: M.B.B.S; D.N.B; M.S. (CR)
City and country of primary residence : Chennai, India
Biography :
Dr. C. Padmapriyadarsini is a Clinician by training and is currently Deputy Director (medical)
in the Department of Clinical Research at the National Institute for Research in Tuberculosis
(NIRT) (formerly known as the Tuberculosis Research Centre), Chennai. She has a Short-
term Fellowship in HIV epidemiology from University of California, Los Angeles and a
Masters Degree in Clinical and Translational Research from Tufts University Boston, USA.
Over the last 15 years, she is involved in multiple clinical studies and trials involving
HIV and TB coinfected adults and children at NIRT. She is the Principle investigator of
multiple collaborative, multicentric projects, both at national and international level. She has
more than 45 publications in peer reviewed national and International journals and 3 book
chapters to her credit. She has been involved in framing National Guidelines for
Management of Extra-pulmonary TB (INDEX TB Guidelines) and Guidelines for the
Introduction of Bedaquiline for drug resistant TB patients in the country. She recently
received the Lupin-TAI Oration award at the National TB Conference 2016, Lucknow, by the
TB Association of India. She is a member of the National Technical Group of RNTCP under
Central TB Division as well as the National Technical Working group for HIV-TB under
NACO, Ministry of Health and Family Welfare, Government of India
Name:
Lucy Chesire
Institutional affiliation(s): Tuberculosis Consortium
Academic degrees: Bachelor of Science in Community Nutrition
City and country of primary residence: Kenya, Nairobi
Biography Reknown Public Health Specialist working at Tuberculosis Advocacy Consortium, a Kenyan
based national NGO as the Executive Director. I have attended my Bachelor of Science
degree in Community Nutrition from Great Lakes University of Kisumu, and rated Second
Class Upper level and currently undertaking Masters in Public Health at the University of
Liverpool-UK. I have served on a number of reputable International Organization Boards ,
Guideline Development working groups, Technical Workings Groups, this include being the
first patient representative on the Stop TB Partnership Coordinating Board, been an advisor
on UNITAID’s Civil Society Team, Board Member- Communities Delegation-GFATM and
Community Delegation member to the board of the Global Fund to Fight AIDS TB and
Malaria, a former member of the TB REACH proposal steering committee of the Stop TB
Partnership, and a former member of the Strategic Technical Advisory Group on TB of the
World Health Organization in 2007. I currently serve on the Kenya Coordinating Mechanism
to the Global Fund, as a member representation Tuberculosis Communities among others.
7 years experience on guideline development include treatment of drug-susceptible
tuberculosis and patient care & support, use of bedaquiline and update on the WHO policy
guidance on the use of delamanid in children among others as a patient/CSO representative.
Name: Betina Durovni
Institutional affiliation(s): Health Secretariat Rio de Janeiro City, Federal University of Rio
de Janeiro;
Academic degrees: MD, PhD
City and country of primary residence: Rio de Janeiro City, Brazil
Biography
Betina Durovni is a medical doctor specialized in infectious diseases whose career started in
the centre of the AIDS epidemic in 1986. Dr Durovni has experience in conducting
operational and clinical research on tuberculosis and HIV. As a Principal Investigator or co-
investigator she has participated in many international collaborative studies on tuberculosis
and tuberculosis associated to HIV. She was the Principal Investigator in Brazil in the
THRIO study part of the CREATE consortium and in the GenXpert pilot study funded by the
B&M Gates foundation, and co-investigator in NIH funded collaborative studies with Johns
Hopkins University on innovative approaches for tuberculosis control. She holds a MBA in
health administration and a PhD in medicine from the Rio de Janeiro Federal University and
a MPH from the Johns Hopkins University. Dr Durovni has served as a consultant for
Brazilian MoH and UNAIDS with experience in several countries, she is a member of the
STAG-TB WHO. More recently, Dr Durovni has become involved in the primary care
reform in Rio de Janeiro and is now the undersecretary for surveillance, promotion and
primary care.
Name: Diana Gibb
Institutional affiliation(s) University College London
Academic degrees
1977 MBChB Distinctions in Medicine, Paediatrics, Pathology (Subtle Gold medal for
medicine) Bristol University
1979 Diploma Obstetrics and Gynaecology Auckland, New Zealand
1982 FRACP Paediatrics (Part 1) Royal Australian College Australia
1985 MRCP Paediatrics Royal College of Physicians, UK
1988 MD Markers of Renal Complications in Diabetic Children Bristol University
1990 MSc Epidemiology London School of Hygiene and Tropical Medicine
City and country of primary residence: Bristol, UK
Biography
Diana is professor of Epidemiology and Programme Leader of the Paediatric Programme of
trials and cohorts at the MRC Clinical trials unit, London. Over the last 20 years she set up
and coordinated a network of clinical trials and cohorts, across Europe, Thailand and South
America mainly addressing questions in paediatric HIV infection. Since 1999 her focus has
expanded to Africa where she runs large trials, addressing strategy questions in adult and
paediatric HIV infection and more recently in malaria and tuberculosis, collaborating widely
with clinical and research centres in 6 countries in East and Southern Africa. Wide inter-
disciplinary collaboration with health economists, pharmacologists, social and basic scientists
and innovators of medicines for children are incorporated into trial programmes. Capacity
development is an important feature of the overseas collaborations, including interactive
courses in paediatric HIV, on-the-ground training in clinical trials and PhD mentorship. She
serves on a number of WHO advisory and guideline committees and continues a clinical
commitment at the HIV Family clinic at the Great Ormond Street Hospital for Children in
London, which she started in 1991.
Name: Stephen Graham
Institutional affiliation(s): Centre for International Child Health, University of Melbourne,
Australia
Consultant in child TB and lung health, The Union, France
Senior Principal Research Fellow, The Burnet Institute, Australia
Group leader, International Child Health, Murdoch Childrens Research Institute, Melbourne
Academic degrees: MB BS, FRACP, DTCH, PhD
City and country of primary residence: Melbourne, Australia
Biography
Steve Graham is a paediatrician with over 20 years of clinical and research experience in
resource-limited settings in a range of childhood diseases, including tuberculosis (TB),
pneumonia and HIV. He has provided technical assistance on child TB to multiple National
TB Programmes (NTPs) in the Asia-Pacific and African regions. Steve was Chair of the Stop
TB Partnership and WHO’s Childhood TB subgroup from 2011 to 2016, is a member of
WHO’s STAG TB, and Chair of WHO WPRO Taskforce on Child TB. He authored the
international Childhood TB Roadmap (2013), WHO’s Guidance on child TB for NTPs (2006
and 2014), The Union’s Deskguide on child TB management, and in 2010 developed the
recommendations for a new fixed dose combinations for treatment of TB in young children.
Steve’s research interest includes implementation of child TB contact screening and LTBI
management in TB-endemic settings - including Malawi and in Indonesia, where he
supervised original prospective evaluation of WHO’s symptom-based child contact screening.
He is currently collaborating on community-based child TB and contact screening projects in
Viet Nam and Uganda. In 2015, he was awarded the Karel Styblo Public Health Prize for
long-standing contributions to child TB and lung health.
Name: Diane Havlir
Institutional affiliation(s): University of California, San Francisco
Academic degrees: MD
City and country of primary residence San Francisco, California, USA
Biography Dr. Diane Havlir is Professor of Medicine at the University of California, San Francisco and
Chief of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital.
She was a physician in training when the AIDS epidemic emerged in the 1980s and has cared
for HIV- infected patients ever since. She has conducted clinical research in TB, HIV and
HIV and TB co-infection for over 25 years, with over 200 publications. She led the HIV/TB
working group of the WHO, plays a leadership role in the WHO HIV Drug Resistance
Surveillance Program and has participated on the WHO Guideline Committee since its
inception. She is currently leading is a community randomized study in East Africa
measuring the health, economic and education effects of testing and treating all HIV infected
persons with a streamlined care approach, with emphasis of assessing his approach on latent
TB infection and incident TB cases.
Name: Sally Hargreaves
Institutional affiliation(s): International Health Unit, Section of Infectious Diseases and
Immunity, Hammersmith Hospital, Imperial College London, London, UK
Academic degrees: MSc, PhD, FRCPE
City and country of primary residence: London, UK
Biography
SH is a social scientist with an interest in migrant health and infectious diseases. She co-leads
a research team at Imperial College London exploring innovative approaches to migrant
screening in the UK and Europe, and has recently led two studies exploring the feasibility of
doing latent TB screening at key health-care portals where newly arrived migrants present (eg,
the Emergency Room). She has an active interest in the expansion across Europe of more
restrictive approaches to provision of statutory health care to migrants, the barriers to care
this group may face, and implications for uptake of latent and active TB screening in
vulnerable migrant groups. She has authored several papers on the subject of migrant
screening, and previously worked on TB-related issues for MSF in Uzbekistan and
throughout the Former Soviet Union. She is the Research Lead for the European ESGITM
Study Group (ESCMID) into migrant and traveller health, focusing on exploring the
development of screening policies for latent and active TB across Europe.
Name: Nadia Ismail Abu Sabrah
Institutional affiliation(s): Tuberculosis consultant Physician and Epidemiologist
Former Assistant Director of Chest Disease Directorate and Migrant's
Health/MOH, Jordan
Head of Tuberculosis Division/MOH, Jordan
Deputy National Tuberculosis Program Manager (NTP)/MOH, Jordan
Surveillance Officer of the NTP/ MOH, Jordan
Head of Integrated Management of Childhood illnesses (IMCI)/MOH,
Jordan
Academic degrees:
1982: Medical Doctor (M.D) Degree, M.B.B.CH, Faculty of Medicine, University of
Alexandria-EYGPT
1998- High Specialty Degree in Community Medicine and Epidemiology, Faculty of
Medicine, Jordan University of Science and Technology/Jordan.
City and country of primary residence: Amman, Jordan
Biography
Dr. Nadia Abu Sabrah is a medical doctors and since 1984 as a staff of the National
Tuberculosis Control Program of the Department of Chest Diseases of MOH,Jordan with 30
years experience on treatment of drug-susceptible tuberculosis and patient care & support and
guideline development. She graduated High Specialty Degree in Community Medicine and
Epidemiology, Faculty of Medicine, Jordan University of Science and Technology /Jordan in
1998. Since 1998 surveillance officer of the NTP, and then Deputy of NTP and assistant
Director of chest Diseases Directorate and Migrant's Health in 2000. She has been involved
in the development of general policies, strategic plans for TB control, training and
educational materials, guidelines, standardized operating procedures and manuals for
infection control and management at TB laboratories and TB management units (TBMUs)
and monitor and follow up the implementation of the National TB Control Program's
activities in the country. She also actively participates in the training of doctors and other
health providers in management of Tuberculosis and Practical Approach to Lung Health
(PAL), and lecturer for post graduate doctors for Diploma in Community Medicine. Dr.Nadia
has been involved in framing and preparing National guidelines for Management of TB and
Drug Resistant TB. She has served as one of the led writers of the National Tuberculosis
Control Strategy and the country's proposal applications (Round5&10) which have been
approved by GFATM. Dr.Nadia has published many studies in the international Journals on
Tuberculosis and PAL and approved to be displayed in the Union World Conferences on
Lung Health.
Name: Alberto Matteelli
Institutional affiliation(s) University of Brescia – WHO Collaborative Centre for TB/HIV
and TB Elimination
Academic degrees: M.D
City and country of primary residence: Brescia, Italy
Biography
He is a specialist in Infectious Diseases and Associate Professor in Infectious Diseases at the
University of Brescia, Brescia, Italy, and Director of the World Health Organization (WHO)
Collaborating Center on Tuberculosis/HIV and TB Elimination, focusing on control of latent
tuberculosis infection (LTBI).
His main fields of interest include TB/HIV co-infection and latent tuberculosis infection.
He served from 2013 to 2015 as a medical officer at the THC Unit, GTB, WHO Geneva,
where he contributed to the development of the 2015 WHO Guidelines on latent tuberculosis
infection. He was involved in the overall agenda for the scale-up of LTBI activities. He
contributed to WHO guidelines development process in other areas, including the
consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV
infection – 2016 recommendations for a public health approach.
Name: Lindiwe Mvusi
Institutional affiliation(s): National Department of Health, South Africa
Academic degrees: B Sc, CDE, MBCHB
City and country of primary residence: Johannesburg, South Africa
Biography
A medical practitioner with post graduate training in occupational and public health
programmes. Sixteen years experience in clinical work in the private and public sectors,
before joining the National Department of Health as TB programme manager. Current
responsibilities include policy formulation, guideline development, strategic plan
development, planning, coordination of training, surveillance, monitoring and evaluating the
implementation of the national policies, overall coordination of the TB programme which
includes the private sector, business/ industry, correctional services and military health
services. I have served as technical advisor on the WHO DOTS Expansion Working Group,
TB/ HIV and MDR-TB Working Groups. I currently serve in the National Essential
Medicines List Committee
Skills and experience
I have been involved in the national guideline development for Tuberculosis, TB Preventive
therapy, Multi drug resistant TB and Infection Prevention and Control. The specific skills and
experience I will be bringing into this process are;
clinical patient management, programmatic management and therefore provide end
user perspectives.
Evidence review
Formulation of the PICO questions
Name: Nandi L Siegfried
Institutional affiliation(s) [current and in the prior four years]
Independent (0.8fte)
Chief Specialist Scientist, Medical Research Council of South Africa (0.2fte)
Associate Professor, Faculty of Health Sciences, University of Cape Town
Academic degrees
MBChB, MPH (Hons), FCPHM (SA), DPhil (Oxon)
City and country of primary residence
Cape Town, South Africa
Biography
I am a South African public health physician working as an independent consultant based in
Cape Town. Following several years in clinical medicine, I transferred to a research career
focused on clinical epidemiology and trials methods. I worked for a decade at senior
management level at the South African Medical Research Council, where I was co-director
of the South African Cochrane Centre and Deputy Co-ordinating Editor of the Cochrane
HIV/AIDS Review Group. In 2011 I commenced working as an independent clinical
epidemiology consultant.
As an independent consultant I provide assistance and guidance, as well as technical support
to international, national, institutional and non-government agencies in the healthcare sector.
Most notable is my role as Chair, Technical Advisor and/or Methodologist to 13 World
Health Organization Clinical Guidelines Development Groups and serving as the South
African representative on the Organization for Cooperation and Economic Development
Working Group on Multinational, Non-commercial Clinical Trials.
I have a thorough knowledge of the methods required for high quality clinical trial conduct,
am highly experienced in systematic review methodology and knowledge translation, and my
public health training affords me a broad perspective across the healthcare arena. As a South
African who has worked in neighbouring African countries, I have experience and
knowledge of the healthcare challenges facing low- and middle-income countries. I have
published widely and enjoy teaching and lecturing.
Name: Liani Smit
Institutional affiliation(s): University of Stellenbosch and Western Cape Department of
Health
City and country of primary residence: Cape Town, South Africa
Academic degrees: MBChB, Dip HIV Management (SA), DCH (SA)
Biography
Liani Smit is a medical doctor and TB advocate with a special interest in genetics and
tuberculosis. After obtaining her medical degree from the University of Stellenbosch, in 2008,
she has worked on the frontline of South Africa’s TB and HIV epidemic. Following a
personal experience with pulmonary TB in 2010, she began advocating for the risks of
occupational TB in healthcare workers as a member of the non-profit organisation, TB Proof.
In 2015 she became a member of the Community Research Advisors Group (CRAG), which
works to ensure the participation and engagement of affected communities in research
conducted by the CDC’s TB Trials Consortium (TBTC). Liani is the CRAG representative on
the LTBI protocol team for the TBTC’s Study 37
Name: Si Thu Aung
Institutional affiliation(s): Programme Manager, NTP Myanmar)
Academic degrees: M.B.,B.S, D.T.C.D, M.P.H
City and country of primary residence: Nay Pyi Taw, Myanmar
Biography Dr. Si Thu Aung is Programme Manager of National TB Programme, under
Department of Public Health, Ministry of Health, Myanmar. He graduated
Diploma in TB & Chest Diseases from University of Medicine (1) in 2003 and
M.P.H from University of Public Health in 2008. His main responsibilities in TB
control in Myanmar are; programme management, coordination with other
implementing partners and research work. He conducted a lot of operational
research in the areas of epidemiology, health system research, nation-wide TB
prevalence, mortality & drug resistance surveys in order to to enhance
utilization of research findings by community, service providers and policy
makers. Under his stewardship, NTP has successfully developed National
Strategic Plan (2016-2020) for TB control in Myanmar. He has been working for
NTP since 2004 and as a programme manager since 2014.
Name: Nguyen Van Hung
Institutional affiliation(s): Department of Microbiology and National Tuberculosis
Reference Laboratory - National Lung Hospital, Vietnam.
Academic degrees: PhD, MD
City and country of primary residence: Hanoi City, Vietnam
I received the MD degree in Hanoi Medical University in 1985, the PhD degree and Assoc
Prof title in Science in Medicine,Vietnam, in 1995 and 2016, respectively. I have 27 years
working experience in Clinical Microbiology at National Lung Hospital, of which the most
recent 11 years have been as the Head of Department and also the Leader of Laboratory
Team under the Vietnam NTP. Vietnam NTP successes were recognized by WHO, in that
Lab network has great contribution. Almost WHO recommended techniques for TB have
been applied with high quality in laboratories. Moreover, NRL succeeded in getting
accredited ISO 15189 from 2012.
In May, 2016, I selected as a member in GLI Core Group of WHO. Regarding to LTBI, I had
the presentation in the first meeting of Global Consultation on the Programmatic
Management of LTBI in Seoul, April, 2016. In present, I have contribute to implementing 02
studies in relative to LTBI (The ACT4 and V-Quin Trial).
Name: Marieke Van der Werf
Institutional affiliation(s): European Centre for Disease Prevention and Control
Academic degrees: MD, PhD, MSc, MPH
City and country of primary residence: Stockholm, Sweden
Biography
Marieke J. van der Werf is the head of the Disease Programme Tuberculosis at the European
Centre for Disease Prevention and Control in Stockholm since 2012 where she is responsible
for the scientific and technical work of the Centre on tuberculosis surveillance, diagnosis,
guidance development, and country support.
She was trained as a medical doctor, in biomedical sciences, and in public health and is a
registered epidemiologist. She obtained her PhD in 2003 and published more than 100
articles in international peer-reviewed journals.
She has worked in Europe, Africa and Asia and provided technical assistance and built
capacity for epidemiological and operational research on topics relevant for tuberculosis
prevention and control. She participated in international policy and guidelines development
groups, such as the World Health Organization STAG-TB and the Task Force Impact
Measurement.
Name: Wim P. Vandevelde
Institutional affiliation(s): Global TB Community Advisory Board
Academic degrees: Bachelor of Laws studies
City and country of primary residence: Cape Town, South Africa
Biography
For more than a decade Wim Vandevelde has been committed to full time action on HIV,
Hepatitis and TB advocacy and Community involvement in medical research in Europe and
globally. Prior to his health advocacy work, Wim worked in the marketing communications
sector and has extensive experience in the banking industry in Europe. A native of Bruges,
Belgium, Wim speaks fluently Dutch, English, French and Portuguese. He lives in Cape
Town, South Africa, since 2012.
Name: Irina A. Vasilyeva
Institutional affiliation(s):
Director 07.2016 To present Research Institute of
Phthisiopulmonology of
I.M. Sechenov First Moscow State
Medical University, 4, Dostoyevsky Str,
Moscow
Chief TB
specialist of
the Ministry
of Health
(MoH) of the
Russian
Federation
(RF)
06.2013 To present MoH RF, Moscow
Head of TB
Department
07.2008 06. 2016 Central TB Research Institute of the
Russian Academy of Medical Sciences
(CTRI RAMS), 2, Yauzskaya alley,
Moscow
Academic degrees: Doctor of Medical Sciences
Professor
City and country of primary residence: Moscow, Russian Federation
Biography
After graduation from the I.M.Sechenov First Moscow Medical Institute, I joined the TB
residency program at the Central TB Research Institute of the Russian Academy of Medical
Science (CTRI RAMS).
In 2008, I became the head of the leading scientific and clinical division of CTRI where an
advance center for multidrug-resistant TB (MDR-TB) was established.
Starting 2013, I combined my work at the CTRI with the responsibilities of the chief non-
staff phthisiologist of the Russian Ministry of Health.
In July 2016, I was appointed as a director of the Research Institute of Phthisiopulmonology
of I.M. Sechenov First Moscow State Medical University.
My research expertise includes various aspects of M/XDR-TB treatment, comorbidities
(TB/HIV, TB, and diabetes mellitus), development of TB chemotherapy regimens based on
molecular genetic methods for diagnosis of mycobacteria drug resistance, as well as
development of measures for TB prevention in patients with HIV and diabetes.
At the present time, being a chief TB expert and the NTP leader, I am responsible for
management of TB care in the Russian Federation. Under my leadership, the following
documents were developed: the 2020 TB care development strategy in the Russian Federation,
the National plan for prevention of M/XDR-TB and TB/HIV transmission, modern
approaches to drug supply management and TB treatment management, and updates of the
legal TB documents; the implementation of the state-of-the-art medical and managerial
technologies in TB practice is in progress.
I am the president of the Russian Society of Phthisiologists, editor-in-chief of the magazine
“TB and Pulmonary Diseases”, a member of the WHO STAG-TB group in 2014-2016.
I have more than 160 scientific publications, including 3 monographs and 6 textbooks for
physicians.